Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ARTISS on latissimus dorsi donor site seroma after breast reconstruction
2014-000727-25Phase 4Terminated
- Sponsor
- Isala
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of porcine fibrin sealant in breast reconstruction (2 arms), sponsored by Isala. Primary endpoint: Total volume of donor site seroma. Started Mar 2017; status: terminated.
02
Drugs
porcine fibrin sealant
03
Conditions
breast reconstruction
Beyond the preview
Go deeper on 2014-000727-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000727-25.